Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2007

01-04-2007

Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation

Authors: Yasushi Onishi, Shin-ichiro Mori, Shigeru Kusumoto, Kyoko Sugimoto, Daigo Akahane, Yuriko Morita-Hoshi, Sung-Won Kim, Takahiro Fukuda, Yuji Heike, Ryuji Tanosaki, Kensei Tobinai, Yoichi Takaue

Published in: International Journal of Hematology | Issue 3/2007

Login to get access
Metadata
Title
Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
Authors
Yasushi Onishi
Shin-ichiro Mori
Shigeru Kusumoto
Kyoko Sugimoto
Daigo Akahane
Yuriko Morita-Hoshi
Sung-Won Kim
Takahiro Fukuda
Yuji Heike
Ryuji Tanosaki
Kensei Tobinai
Yoichi Takaue
Publication date
01-04-2007
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2007
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.06199

Other articles of this Issue 3/2007

International Journal of Hematology 3/2007 Go to the issue

OriginalPaper

Outcome of Non-T-Cell-Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation from Family Donors in Children and Adolescents

OriginalPaper

Bacterial Bloodstream Infection in Neutropenic Adult Patients after Myeloablative Cord Blood Transplantation: Experience of a Single Institution in Japan

OriginalPaper

Detection ofNOTCH1 Mutations in Adult T-cell Leukemia/Lymphoma and Peripheral T-Cell Lymphoma

OriginalPaper

Cyclosporine Therapy for Acquired Aplastic Anemia: Predictive Factors for the Response and Long-term Prognosis

Letter to the Editor

Successful Treatment with Imatinib Combined with Less Intensive Chemotherapy (Vincristine and Dexamethasone) as Induction Therapy in a Very Elderly Patient with Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia

Case Report

Reversible Cardiomyopathy Associated with Multicentric Castleman Disease: Successful Treatment with Tocilizumab, an Anti—Interleukin 6 Receptor Antibody
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits